"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares a shocking new forecast
Click here for the name of the one ticker you need
Andrew Okun, insider at PerkinElmer

Andrew Okun Insider Information

Insider of PerkinElmer

Mr. Okun serves as Vice President and Chief Accounting Officer, a position in which he has served since April 2011. Mr. Okun joined us in 2001 and has served in financial and controllership positions of increasing responsibility, including Director of Finance for the Optoelectronics business from 2001 through 2005, Vice President of Finance from 2005 through 2009 and Vice President and Corporate Controller from 2009 through 2011. Prior to joining us, Mr. Okun most recently worked for Honeywell International as a Site Controller as well as for Coopers & Lybrand.

Mr. Okun is a Certified Public Accountant and earned his Master of Business Administration from the University of Virginia. He completed his undergraduate degree at the University of Santa Barbara.

What is Andrew Okun's net worth?

The estimated net worth of Andrew Okun is at least $1.01 million as of August 1st, 2022. Mr. Okun owns 6,391 shares of PerkinElmer stock worth more than $1,009,203 as of August 15th. This net worth estimate does not reflect any other assets that Mr. Okun may own. Learn More about Andrew Okun's net worth.

How old is Andrew Okun?

Mr. Okun is currently 52 years old. There are 8 older executives and no younger executives at PerkinElmer. The oldest executive at PerkinElmer is Mr. Robert Francis Friel, Advisor, who is 66 years old. Learn More on Andrew Okun's age.

How do I contact Andrew Okun?

The corporate mailing address for Mr. Okun and other PerkinElmer executives is 940 WINTER STREET, WALTHAM MA, 02451. PerkinElmer can also be reached via phone at (781) 663-6900 and via email at [email protected] Learn More on Andrew Okun's contact information.

Has Andrew Okun been buying or selling shares of PerkinElmer?

During the last ninety days, Andrew Okun has sold $524,877.66 in PerkinElmer stock. Most recently, Andrew Okun sold 3,173 shares of the business's stock in a transaction on Monday, August 1st. The shares were sold at an average price of $165.42, for a transaction totalling $524,877.66. Following the completion of the sale, the insider now directly owns 6,391 shares of the company's stock, valued at $1,057,199.22. Learn More on Andrew Okun's trading history.

Who are PerkinElmer's active insiders?

PerkinElmer's insider roster includes Peter Barrett (Director), Joel Goldberg (Insider), Sylvie Gregoire (Director), James Mock (Insider), Andrew Okun (Insider), Prahlad Singh (Insider), and Daniel Tereau (Insider). Learn More on PerkinElmer's active insiders.

Are insiders buying or selling shares of PerkinElmer?

During the last twelve months, insiders at the medical research company sold shares 6 times. They sold a total of 30,220 shares worth more than $4,989,881.45. The most recent insider tranaction occured on August, 1st when insider Andrew Okun sold 3,173 shares worth more than $524,877.66. Insiders at PerkinElmer own 0.5 % of the company. Learn More about insider trades at PerkinElmer.

Information on this page was last updated on 8/1/2022.

Andrew Okun Insider Trading History at PerkinElmer

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/1/2022Sell3,173$165.42$524,877.666,391View SEC Filing Icon  
6/10/2021Sell2,370$145.71$345,332.70
11/6/2020Sell6,107$140.14$855,834.9816,417View SEC Filing Icon  
7/29/2020Sell6,699$120.00$803,880.0017,009View SEC Filing Icon  
12/4/2019Sell11,984$94.12$1,127,934.08
3/19/2019Sell16,788$95.03$1,595,363.6425,670View SEC Filing Icon  
2/8/2018Sell2,324$75.44$175,322.568,876View SEC Filing Icon  
2/5/2018Sell2,273$77.86$176,975.78View SEC Filing Icon  
12/15/2017Sell12,680$72.00$912,960.0025,121View SEC Filing Icon  
6/19/2017Sell4,358$65.00$283,270.0016,799View SEC Filing Icon  
3/20/2017Sell3,000$57.27$171,810.0012,441View SEC Filing Icon  
10/23/2015Sell2,000$50.00$100,000.0011,278View SEC Filing Icon  
3/23/2015Sell2,000$50.09$100,180.00View SEC Filing Icon  
2/9/2015Sell6,262$45.82$286,924.84View SEC Filing Icon  
3/7/2014Sell9,398$46.35$435,597.3013,816View SEC Filing Icon  
9/6/2013Sell6,805$36.86$250,832.30View SEC Filing Icon  
See Full Table

Andrew Okun Buying and Selling Activity at PerkinElmer

This chart shows Andrew Okun's buying and selling at PerkinElmer by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PerkinElmer Company Overview

PerkinElmer logo
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Read More

Today's Range

Now: $157.65
Low: $156.11
High: $158.31

50 Day Range

MA: $145.45
Low: $132.37
High: $160.96

2 Week Range

Now: $157.65
Low: $130.65
High: $203.16

Volume

485,693 shs

Average Volume

828,152 shs

Market Capitalization

$19.90 billion

P/E Ratio

29.52

Dividend Yield

0.18%

Beta

1.12
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!